Connect your AI

Biohaven BHVN Debt Instrument, Fair Value Disclosure

Debt Instrument, Fair Value Disclosure at other companies

BlackstoneBX

$11.95B+6.6%

MSCIMSCI

$6.13B+44.7%

Apollo Global ManagementAPO

$13.47B+32.4%

LennarLEN

$4.11B+85.3%

KEE

Keel Infrastructure Corp. Common StockKEEL

$590.25M—

Arthur J. GallagherAJG

$12.18B—

Other financials

Income statement

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

Market cap$2.25B-48.1%

Enterprise value$2.26B-46.3%

Returns & leverage

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentFairValue.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's debt instrument, fair value disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biohaven's debt instrument, fair value disclosure?: Biohaven (BHVN) reported debt instrument, fair value disclosure of $241.91M in Q1 2026.